How big is UnitedHealth Group, Inc.?

As of Jun 18, UnitedHealth Group, Inc. has a market capitalization of $280.19 billion, with a net profit of $22.94 billion over the last four quarters and total assets of $302.10 billion.

As of Jun 18, UnitedHealth Group, Inc. has a market capitalization of 280,188.46 million, categorizing it as a Large Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is 22,937.00 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 92,658.00 million and Total Assets at 302,102.00 million.

What does UnitedHealth Group, Inc. do?

UnitedHealth Group, Inc. is a large health and well-being company in the Healthcare Services industry, with a market cap of approximately $280 billion and a recent net profit of $6.47 billion. Key metrics include a P/E ratio of 12.00 and a dividend yield of 209.00%.

Overview:<BR>UnitedHealth Group, Inc. is a health and well-being company operating in the Healthcare Services industry, categorized as a Large Cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Profit: 6,474 Million (Quarterly Results - Mar 2025)<BR>Market cap: USD 280,188.46 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 12.00<BR>Dividend Yield: 209.00%<BR>Debt Equity: 0.49<BR>Return on Equity: 24.13%<BR>Price to Book: 2.95<BR><BR>Contact Details:<BR>Address: 9900 Bren Rd E, HOPKINS MN: 55343-9664<BR>Tel: ['1 952 9361300', '1 800 3285979']<BR>Fax: 1 302 6555049<BR>Website: http://www.unitedhealthgroup.com/

Should I buy, sell or hold UnitedHealth Group, Inc.?

Who are in the management team of UnitedHealth Group, Inc.?

As of March 2022, the management team of UnitedHealth Group, Inc. includes Non-Executive Chairman Stephen Hemsley, Lead Independent Director Richard Burke, and Independent Directors William Ballard, Timothy Flynn, and Michele Hooper. They are responsible for the company's governance and oversight.

As of March 2022, the management team of UnitedHealth Group, Inc. includes the following individuals:<BR><BR>- Mr. Stephen Hemsley, Non-Executive Chairman of the Board<BR>- Mr. Richard Burke, Lead Independent Director<BR>- Mr. William Ballard, Independent Director<BR>- Mr. Timothy Flynn, Independent Director<BR>- Ms. Michele Hooper, Independent Director<BR><BR>These individuals play key roles in the governance and oversight of the company.

Is UnitedHealth Group, Inc. overvalued or undervalued?

As of September 9, 2025, UnitedHealth Group, Inc. is considered overvalued with a P/E ratio of 12, an EV to EBITDA ratio of 77.36, and a year-to-date return of -33.81%, significantly underperforming the S&P 500.

As of 9 September 2025, the valuation grade for UnitedHealth Group, Inc. has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently considered overvalued, with a P/E ratio of 12, which is lower than its peers such as The Cigna Group at 15.76 and Elevance Health, Inc. at 12.97. Additionally, the EV to EBITDA ratio stands at 77.36, significantly higher than the industry average, and the PEG ratio is notably low at 0.28, suggesting that growth expectations may not justify the current price.<BR><BR>In terms of performance, UnitedHealth has underperformed relative to the S&P 500, with a year-to-date return of -33.81% compared to the index's 12.22%. Over the past year, the stock has declined by 42.34%, while the S&P 500 has gained 17.14%. This stark contrast in returns further reinforces the notion that UnitedHealth Group, Inc. is currently overvalued.

Is UnitedHealth Group, Inc. technically bullish or bearish?

As of October 31, 2025, UnitedHealth Group, Inc. shows a mildly bearish trend with mixed technical signals, underperforming the S&P 500 significantly year-to-date and over the past year.

As of 31 October 2025, the technical trend for UnitedHealth Group, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD and Bollinger Bands indicate a bearish stance. Daily moving averages are bearish, and the Dow Theory shows a mildly bearish signal on the weekly chart while being mildly bullish on the monthly chart. The KST is bullish weekly but bearish monthly. <BR><BR>The stock has underperformed significantly against the S&P 500, with a year-to-date return of -34.60% compared to the S&P 500's 16.30%, and a one-year return of -41.71% versus 19.89% for the index. Overall, the current technical stance is mildly bearish, reflecting the mixed signals across different time frames.